An educator with more than 30 years of experience, Robert Oster of the University of Alabama has provided statistical expertise to universities, government agencies, and contract research organizations. An ASA Fellow, Oster has served the ASA in many capacities.
medicine
James McCune Smith
James McCune Smith was the first professionally trained Black physician to practice in the United States. Smith’s work pioneered the use of statistical evidence to evaluate the efficacy of medical treatments and dismantle racist claims of Black biological inferiority.
Holan Elected to NASEM Panel
ASA member Scott H. Holan has been selected to serve on the National Academies of Sciences, Engineering, and Medicine’s study panel, “Foundation Models for Scientific Discovery and Innovation: Opportunities Across the Department of Energy.”
Registration Open for Symposium on AI in Pharmaceutical Medicine
The symposium, which can be attended in person or virtually, will take place June 10–11 at the Northeastern University campus in Boston with the theme Generative AI in Medical Research and Drug Development: Hype or Reality?
First Rousseeuw Prize Awarded for Work on Causal Inference
The King Baudouin Foundation has awarded the prize, worth $1 million, to James Robins, Miguel Hernán, Thomas Richardson, Andrea Rotnitzky, and Eric Tchetgen for their pioneering work on causal inference with applications in medicine and public health.
People News for August 2022
Read about what ASA members have been up to recently.
Win $300 in Statistical Significance Competition
Statistical Significance is a one-page illustration of the value of statistics to society. The objective is to illustrate to a lay person how the statistical solution to the problem presented would help form decisions that improve society.
Data for Good Can Drive COVID Vaccine Confidence
David Corliss says statisticians can help address the distrust of vaccines, a large challenge of this phase of the COVID-19 pandemic.
Pharma Executive Offers Thoughts About COVID-19
Dr. Amrit Ray, global president, R&D and Medical, Upjohn Division, Pfizer Inc., offers his thoughts about the COVID-19 pandemic and how to best protect yourself and your family.
ASA to Cosponsor AI in Clinical Drug Development Symposium in May
The Pfizer/ASA/Columbia University Symposium on Risks and Opportunities of AI in Clinical Drug Development aims to advance the use of artificial intelligence (AI) in drug development and deployment.